Thursday - March 19, 2026

Category Archives: Pharmaceuticals & Biotech

Sickle Cell Disease Market: Investment-Ready Growth Trends to 2034 – DelveInsight | BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharma, Beam Therapeutics Inc., Graphite Bio, Roche, Quercis

The Key Sickle Cell Disease Companies in the market include – BRL Medicine, Oryzon Genomics, GlaxoSmithKline, Agios Pharmaceuticals, Beam Therapeutics Inc., Graphite Bio, Roche, Quercis Pharma, Editas Medicin, Pfizer, Emmaus Medical, Inc, Vertex Pharmaceuticals, CRISPR therapeutics, Bluebird Bio, Pfizer, Novo … Continue reading →

Peripheral T Cell Lymphomas Pipeline 2026: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Celleron Therapeutics, Myeloid Therapeutics, Astex Pharma, Citius Pharma, Innate

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Peripheral T Cell Lymphomas pipeline constitutes 40+ key companies continuously working towards developing 40+ Peripheral T Cell Lymphomas treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of … Continue reading →

Projecting the Global Orthopedic Trauma Devices Market Size to Expand at a 5.89% CAGR Through 2032, DelveInsight Analysis

Orthopedic Trauma Devices Market Insights, Competitive Landscape, and Market Forecast – 2032” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The orthopedic trauma devices market is largely … Continue reading →

Multiple Myeloma Market: Pharma Pipeline Fuels Rapid Expansion by 2034 – DelveInsight | Carsgen Therapeutics, Cartesian Therapeutics, Gracell Biotechnology Shanghai Co., Ltd., CASI Pharma, Sorrento

The Key Multiple Myeloma Companies in the market include – Carsgen Therapeutics, Cartesian Therapeutics, Gracell Biotechnology Shanghai Co., Ltd., CASI Pharmaceuticals, Sorrento Therapeutics, Johnson & Johnson Innovative Medicine, Bristol-Myers Squibb and Bluebird bio, Sanofi, and others.   DelveInsight’s “Multiple Myeloma … Continue reading →

Projecting the Global Allergy Diagnostics Market Size to Expand at a 13.16% CAGR Through 2034, DelveInsight Analysis

Allergy Diagnostics Market Insights, Competitive Landscape, and Market Forecast – 2034” report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers.   As per DelveInsight’s assessment, The allergy diagnostics market is primarily fueled by … Continue reading →

Myotonic Dystrophy Pipeline 2026: FDA Approvals and Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight | Dyne Therapeutics, Avidity Biosciences, Harmony Biosciences, AMO Pharma

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myotonic Dystrophy pipeline constitutes 20+ key companies continuously working towards developing 22+ Myotonic Dystrophy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes … Continue reading →

Myopia Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Ziemer Group, NIDEK CO., LTD, 2EyesVision, Carl Zeiss AG, Alcon, CooperVision, Topcon Healthcare

(Las Vegas, Nevada, United States) As per DelveInsight’s assessment, globally, Myopia pipeline constitutes 8+ key companies continuously working towards developing 10+ Myopia treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.   … Continue reading →